The Year in Review 2023

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri Ischemix Press Release for CMX 2043 Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's Virpax Press Release for AnQlar Press Releases Altasciences Receives 2023 CRO Leadership Award for Capabilities Best Global CRO/CDMO 2023 Scrip Awards 2023 Awards and Recognition *****Nonclinical Safety Assessment for Gene Therapy Products—Key Considerations A Square Peg in a Round Hole–Navigating the Unique Attributes of Psychedelic Drug Development Downsized Miniature Swine: A New Spin on the Oldest Model The Altascientist: Webinars and Podcast ACT2023 - Proposed Best Practices for Optimizing the Number of Animals in Toxicology Studies ACT2023 Historical Review of In-Life Data From Studies Utilizing AAVs for Gene Therapy AAPS PharmSci 360 2023 Retrospective Safety Evaluation of Tyrosine Kinase Inhibitor Products Scientific Publications Safety Assessment for Ophthalmic Products eBook Large Molecule Proactive Drug Development eBook Scratching the Surface of Dermal Testing eBook Altasciences eBooks FDA Guidance for Industry Psychedelic Drugs Considerations for Clinical Investigations Successful Manufacturing of Clinical Trial Supply Tips to Ensure Successful Formulation for Nonclinical Testing The Altascientist: Webinars and Podcast The Altascientist ISSUE NO. 32 — A Changing Paradigm for Non-Rodent Species in Nonclinical Safety Studies The Altascientist ISSUE NO. 33 — End-to-End CNS Drug Development Solutions The Altascientist ISSUE NO. 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics The Altascientist ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs The Altascientist ISSUE NO. 36 — Nonclinical Studies in Cell and Gene Therapy The Altascientist ISSUE NO. 37 — Quantitative PCR (qPCR) and Droplet Digital (ddPCR) – Leading-Edge Analysis for Your Gene Therapy Programs The Altascientist Click here to listen! Tell Us Once Think Canada Think Canada Think Canada Accelerate your data with our co-located clinic and lab Accelerate your data with our co-located clinic and lab When you Choose the Right Partner, You Only Need One When you Choose the Right Partner, You Only Need One Inside Look at Ophthalmic Early Clinical Research with Dr. William Foster Inside Look at Ophthalmic Early Clinical Research with Dr. William Foster Natasha Savoie Natasha Savoie Marta Rodriguez Marta Rodriguez Amber Malloy Amber Malloy Michelle Newby Michelle Newby Watch all the Ask an Altascientist videos here! Ben Reed Catherine Konidas, Chief Administrative Officer Catherine Konidas, Chief Administrative Officer Dr. Gaetano Morelli, Chief Medical Officer Dr. Gaetano Morelli, Chief Medical Officer Chris Perkin Chris Perkin Steve Mason Steve Mason Marie-Hélène Raigneau Marie-Hélène Raigneau Dr. Lynne Le Sauteur Dr. Lynne Le Sauteur Happy Holidays

Continue Reading

Top Life Science Resources for Fall 2024
Optimizing for Success: How Sponsors Can Overcome the Challenges in Early-Phase Drug Development
Five Promising Treatment Areas in Early-Phase Drug Development in 2024
Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

2024 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy